[HTML][HTML] Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review
S Dawood, K Broglio, AU Buzdar… - Journal of clinical …, 2010 - ncbi.nlm.nih.gov
S Dawood, K Broglio, AU Buzdar, GN Hortobagyi, SH Giordano
Journal of clinical oncology, 2010•ncbi.nlm.nih.govPrognosis of Women With Metastatic Breast Cancer by HER2 Status and Trastuzumab
Treatment: An Institutional-Based Review - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J
Clin Oncol PMC2799236 Other Formats PDF (164K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Treatment: An Institutional-Based Review - PMC Back to Top Skip to main content NIH NLM
Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Search PMC Full-Text Archive Search in PMC Advanced Search User Guide Journal List J
Clin Oncol PMC2799236 Other Formats PDF (164K) Actions Cite Collections Share
Permalink Copy RESOURCES Similar articles Cited by other articles Links to NCBI …
Abstract
Purpose
The purpose of this study was to determine whether trastuzumab improves prognosis of women with metastatic human epidermal growth factor receptor 2 (HER2)/neu–positive breast cancer beyond that of women with HER2/neu-negative disease.
ncbi.nlm.nih.gov